Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas
Yue-Lin Zhang,1,2,* Tan-Yang Zhou,1,2,* Jing Ai,3,* Sheng-Qun Chen,1,2,* Feng Chen,4 Chun-Hui Nie,1,2 Xin-Hua Chen,1,2 Guan-Hui Zhou,1,2 Hong-Liang Wang,1,2 Tong-Yin Zhu,1,2 Bao-Quan Wang,1,2 Zi-Niu Yu,1,2 Li Jing,1,2 Li-Ming Wu,1,2 Shu-Sen Zheng,1,2 Jun-Hui Sun1,2 1Hepatobiliary and Pancreatic Inte...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/gene-therapy-with-cytosine-deaminase-and-endostatin-fusion-gene-mediat-peer-reviewed-article-CMAR |
id |
doaj-fdc49fd9b9c7466cbd43905ec4ead58b |
---|---|
record_format |
Article |
spelling |
doaj-fdc49fd9b9c7466cbd43905ec4ead58b2020-11-25T02:38:16ZengDove Medical PressCancer Management and Research1179-13222020-04-01Volume 123023303153435Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in HepatomasZhang YLZhou TYAi JChen SQChen FNie CHChen XHZhou GHWang HLZhu TYWang BQYu ZNJing LWu LMZheng SSSun JHYue-Lin Zhang,1,2,* Tan-Yang Zhou,1,2,* Jing Ai,3,* Sheng-Qun Chen,1,2,* Feng Chen,4 Chun-Hui Nie,1,2 Xin-Hua Chen,1,2 Guan-Hui Zhou,1,2 Hong-Liang Wang,1,2 Tong-Yin Zhu,1,2 Bao-Quan Wang,1,2 Zi-Niu Yu,1,2 Li Jing,1,2 Li-Ming Wu,1,2 Shu-Sen Zheng,1,2 Jun-Hui Sun1,2 1Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, People’s Republic of China; 2Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, Zhejiang Province, People’s Republic of China; 3Eye Centre, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang Province, People’s Republic of China; 4Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun-Hui SunHepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, People’s Republic of ChinaTel +86 571 8723 6815Email 1307005@zju.edu.cnFeng ChenDepartment of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, People’s Republic of ChinaTel +86 571 8723 6815Email chenfenghz@zju.edu.cnPurpose: Gene-targeting therapy provides a novel therapeutic approach for tumor treatment using genetically modified endothelial progenitor cells (EPCs) as cellular carriers. This study applied EPCs armed with cytosine deaminase (CD) and endostatin (ES) fusion gene in liver cancer to explore its therapeutic effect.Materials and Methods: EPCs from heart blood of male BALB/c nude mice were cultured and transfected with CD and ES fusion gene. Subsequently, these genetically modified cells were injected into mice bearing hepatoma through their tail veins. The tumor volumes and cell apoptosis were followed up.Results: Tumor volume in the group injected CD/ES-EPCs greatly decreased. The positive rate of VEGF and CD31 in the tumor tissue was lowest in the CD/ES-EPC group. Furthermore, the number of apoptotic cells was highest in the CD/ES-EPC group.Conclusion: The EPCs transfected with CD/ES inhibited tumor growth and preferentially induced tumor cell apoptosis, providing a novel methodology for cancer-targeting therapy.Keywords: gene-targeting therapy, endothelial progenitor cell, endostatin, cytosine deaminase, hepatoma, transfectionhttps://www.dovepress.com/gene-therapy-with-cytosine-deaminase-and-endostatin-fusion-gene-mediat-peer-reviewed-article-CMARgene-targeting therapyendothelial progenitor cellendostatincytosine deaminasehepatomatransfection |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhang YL Zhou TY Ai J Chen SQ Chen F Nie CH Chen XH Zhou GH Wang HL Zhu TY Wang BQ Yu ZN Jing L Wu LM Zheng SS Sun JH |
spellingShingle |
Zhang YL Zhou TY Ai J Chen SQ Chen F Nie CH Chen XH Zhou GH Wang HL Zhu TY Wang BQ Yu ZN Jing L Wu LM Zheng SS Sun JH Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas Cancer Management and Research gene-targeting therapy endothelial progenitor cell endostatin cytosine deaminase hepatoma transfection |
author_facet |
Zhang YL Zhou TY Ai J Chen SQ Chen F Nie CH Chen XH Zhou GH Wang HL Zhu TY Wang BQ Yu ZN Jing L Wu LM Zheng SS Sun JH |
author_sort |
Zhang YL |
title |
Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas |
title_short |
Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas |
title_full |
Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas |
title_fullStr |
Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas |
title_full_unstemmed |
Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas |
title_sort |
gene therapy with cytosine deaminase and endostatin fusion gene mediated by endothelial progenitor cells in hepatomas |
publisher |
Dove Medical Press |
series |
Cancer Management and Research |
issn |
1179-1322 |
publishDate |
2020-04-01 |
description |
Yue-Lin Zhang,1,2,* Tan-Yang Zhou,1,2,* Jing Ai,3,* Sheng-Qun Chen,1,2,* Feng Chen,4 Chun-Hui Nie,1,2 Xin-Hua Chen,1,2 Guan-Hui Zhou,1,2 Hong-Liang Wang,1,2 Tong-Yin Zhu,1,2 Bao-Quan Wang,1,2 Zi-Niu Yu,1,2 Li Jing,1,2 Li-Ming Wu,1,2 Shu-Sen Zheng,1,2 Jun-Hui Sun1,2 1Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, People’s Republic of China; 2Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, Zhejiang Province, People’s Republic of China; 3Eye Centre, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang Province, People’s Republic of China; 4Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun-Hui SunHepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, People’s Republic of ChinaTel +86 571 8723 6815Email 1307005@zju.edu.cnFeng ChenDepartment of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, People’s Republic of ChinaTel +86 571 8723 6815Email chenfenghz@zju.edu.cnPurpose: Gene-targeting therapy provides a novel therapeutic approach for tumor treatment using genetically modified endothelial progenitor cells (EPCs) as cellular carriers. This study applied EPCs armed with cytosine deaminase (CD) and endostatin (ES) fusion gene in liver cancer to explore its therapeutic effect.Materials and Methods: EPCs from heart blood of male BALB/c nude mice were cultured and transfected with CD and ES fusion gene. Subsequently, these genetically modified cells were injected into mice bearing hepatoma through their tail veins. The tumor volumes and cell apoptosis were followed up.Results: Tumor volume in the group injected CD/ES-EPCs greatly decreased. The positive rate of VEGF and CD31 in the tumor tissue was lowest in the CD/ES-EPC group. Furthermore, the number of apoptotic cells was highest in the CD/ES-EPC group.Conclusion: The EPCs transfected with CD/ES inhibited tumor growth and preferentially induced tumor cell apoptosis, providing a novel methodology for cancer-targeting therapy.Keywords: gene-targeting therapy, endothelial progenitor cell, endostatin, cytosine deaminase, hepatoma, transfection |
topic |
gene-targeting therapy endothelial progenitor cell endostatin cytosine deaminase hepatoma transfection |
url |
https://www.dovepress.com/gene-therapy-with-cytosine-deaminase-and-endostatin-fusion-gene-mediat-peer-reviewed-article-CMAR |
work_keys_str_mv |
AT zhangyl genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT zhouty genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT aij genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT chensq genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT chenf genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT niech genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT chenxh genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT zhough genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT wanghl genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT zhuty genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT wangbq genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT yuzn genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT jingl genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT wulm genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT zhengss genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas AT sunjh genetherapywithcytosinedeaminaseandendostatinfusiongenemediatedbyendothelialprogenitorcellsinhepatomas |
_version_ |
1724791730633441280 |